Versant Venture Management as of June 30, 2019
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 9 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 58.3 | $200M | 4.2M | 47.10 | |
| Veracyte (VCYT) | 20.0 | $69M | 2.4M | 28.51 | |
| Gritstone Oncology Ord (GRTS) | 10.1 | $35M | 3.1M | 11.14 | |
| Audentes Therapeutics | 6.1 | $21M | 554k | 37.86 | |
| Ocular Therapeutix (OCUL) | 2.8 | $9.7M | 2.2M | 4.40 | |
| Cymabay Therapeutics | 1.1 | $3.9M | 544k | 7.16 | |
| Second Sight Med Prods | 1.1 | $3.6M | 4.5M | 0.80 | |
| Clovis Oncology | 0.4 | $1.5M | 102k | 14.87 | |
| Opgen | 0.0 | $40k | 102k | 0.39 |
